Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors
多基因面板测试和不同种族/民族的年轻乳腺癌幸存者之间的家庭风险沟通的决策支持
基本信息
- 批准号:10434656
- 负责人:
- 金额:$ 15.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAddressAdvisory CommitteesAgeAreaAsianAttitudeBRCA1 geneBRCA2 geneBehaviorBehavior TherapyBehavioralBeliefBiologicalBlack raceBloodBreast Cancer PatientBreast Cancer PreventionBreast Cancer survivorCancer ControlCancer SurvivorshipCancer-Predisposing GeneCaringClinicalCommunicationConflict (Psychology)Cross-Sectional StudiesCultural DiversityDataDecision AidDecision MakingDiagnosisEducational workshopEthicsEthnic groupExposure toFailureFamilyFamily history ofFamily memberFeasibility StudiesFeedbackFloridaFrequenciesFundingGenesGeneticGenetic ResearchGenetic RiskGenomic medicineGenomicsGoalsHealth Disparities ResearchHereditary Breast and Ovarian Cancer SyndromeHispanicIndividualInheritedInterventionIntervention StudiesInterviewK-Series Research Career ProgramsKnowledgeLatinaLeadershipMalignant NeoplasmsMalignant neoplasm of ovaryMeasuresMentored Research Scientist Development AwardMethodologyMethodsMinorityMinority WomenNational Cancer InstituteNational Comprehensive Cancer NetworkNot Hispanic or LatinoOncogenesOncologyOnline SystemsPALB2 geneParticipantPathogenicityPatient EducationPatientsPenetrancePopulationPopulation InterventionPredispositionPreventive serviceProductivityPublic HealthRaceRandomizedRandomized Controlled TrialsRecording of previous eventsReduce health disparitiesRelative RisksResearchResearch InstituteResearch PersonnelResearch Project GrantsRiskRisk ReductionScienceScreening for cancerSocioeconomic StatusTest ResultTestingTimeTrainingUnderserved PopulationUnited States National Institutes of HealthVariantWomanWritingbasebiobehaviorcancer geneticscancer health disparitycancer riskcareerclinical applicationethnic diversityethnic minorityexperiencegenetic panel testgenetic risk assessmentgenetic testinghealth disparitymalignant breast neoplasmprimary outcomepsychosocialracial and ethnicracial and ethnic disparitiesracial minorityrecruitsecondary outcomeskillsusabilityuser centered designvariant of unknown significanceyoung woman
项目摘要
Project Summary/Abstract:
The introduction of multi-gene panel testing for hereditary breast and ovarian cancer (HBOC) syndrome has
rapidly changed the clinical approach to genetic testing for patients and their families. Young breast cancer
survivors (YBCS), diagnosed at age ≤50 years old, may have inherited a pathogenic/likely pathogenic (P/LP)
variant in a breast cancer susceptibility gene, e.g., BRCA1, BRCA2, PALB2, etc. Recent studies have found
suboptimal rates of genetic testing among young breast cancer patients with less than 50% completion rates for
hereditary breast and ovarian cancer (HBOC) syndrome. Racial and ethnic disparities in genetic testing
completion and results have been well documented. My long-term career goal is to become a leading
independent investigator in breast cancer prevention and control, focusing on cancer genetics/genomics, risk
communication, biobehavioral oncology, and reduction of cancer health disparities among racial/ethnic minority
women. The specific aims are: In Aim 1, we propose to identify factors associated with completion of HBOC
multigene panel testing, cancer risk-reducing behaviors, and family risk communication among racially/ethnically
diverse young breast cancer survivors (YBCS) (N=300) within a sequential explanatory mixed-methods study.
In addition, we will conduct qualitative interviews with (N=40) YBCS who completed genetic testing and those
who have not completed genetic testing to explore knowledge, attitudes, beliefs about genetic testing, and to
identify barriers and facilitators to the communication of genetic risk to their at-risk relatives. We will illuminate
quantitative findings with qualitative data collected. In Aim 2, we will apply user-centered design to modify the
existing genetic testing module within the RealRisks decision aid to meet the needs of YBCS and to add family
risk communication content and conduct participatory workshops and usability testing (N=20). Lastly, in Aim 3,
we will conduct a pilot randomized controlled trial of standard patient education alone or in combination with the
modified RealRisks decision aid among racially/ethnically diverse YBCS. This career development award will
provide me with protected time and the opportunity to pursue my training goals in several targeted areas: (1):
Acquire and apply advanced statistical analytics for conducting mixed methodology and intervention research;
(2) increase knowledge and skills in biobehavioral oncology, cancer survivorship, clinical application of
genetic/genomic medicine, risk communication in families, cascade genetic testing, adapting web-based
decision support interventions for underserved populations, and breast cancer health disparities; (3) gain didactic
and experiential learning in the conduct of randomized controlled trials; and (4) develop leadership skills in the
ethical conduct of scientific research, grant writing, increasing scholarly productivity, and management skills for
scientific independence. In summary, this Mentored Research Scientist Development Award to Promote
Diversity will provide me with invaluable experiences to successfully transition into a scientific independence,
ultimately reducing health disparities.
项目概要/摘要:
遗传性乳腺癌和卵巢癌(HBOC)综合征的多基因面板测试的引入,
迅速改变了对患者及其家属进行基因检测的临床方法。青年乳腺癌
在年龄≤50岁时诊断的幸存者(YBCS)可能遗传了致病性/可能致病性(P/LP)
乳腺癌易感基因的变异,例如,BRCA 1、BRCA 2、PALB 2等。
年轻乳腺癌患者的基因检测率低于50%,
遗传性乳腺癌和卵巢癌(HBOC)综合征基因检测中的种族和民族差异
完成情况和结果都有详细记录。我的长期职业目标是成为一名
乳腺癌预防和控制的独立研究者,重点研究癌症遗传学/基因组学、风险
沟通、生物行为肿瘤学和减少少数种族/族裔之间的癌症健康差异
妇女具体目标是:在目标1中,我们建议确定与完成HBOC相关的因素
多基因面板测试,癌症风险降低行为,以及种族/民族之间的家庭风险沟通
不同的年轻乳腺癌幸存者(YBCS)(N=300)在一个连续的解释性混合方法研究。
此外,我们将对(N=40)完成基因检测的YBCS和那些
没有完成基因检测的人,探索关于基因检测的知识、态度和信念,
找出遗传风险传达给其高危亲属的障碍和促进因素。我们将照亮
收集定性数据的定量结果。在目标2中,我们将应用以用户为中心的设计来修改
RealRisks决策辅助工具中的现有基因检测模块,以满足YBCS的需求并增加家庭
风险沟通内容,并开展参与式研讨会和可用性测试(N=20)。最后,在目标3中,
我们将进行一项试验性随机对照试验,单独进行标准患者教育或与
在种族/民族多样化的YBCS中修改RealRisks决策辅助。该职业发展奖将
为我提供受保护的时间和机会,在几个目标领域追求我的培训目标:(1):
获取和应用先进的统计分析进行混合方法和干预研究;
(2)提高生物行为肿瘤学、癌症生存率、
遗传/基因组医学,家庭风险沟通,级联基因检测,适应网络
决策支持干预服务不足的人群,和乳腺癌的健康差距;(3)获得教学
和经验学习的随机对照试验的行为;和(4)发展领导技能,
科学研究的道德行为,赠款写作,提高学术生产力和管理技能,
科学独立。总之,这个指导研究科学家发展奖,以促进
多样性将为我提供宝贵的经验,成功地过渡到科学的独立,
最终缩小健康差距。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tarsha Jones其他文献
Tarsha Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tarsha Jones', 18)}}的其他基金
Decision Support for Multigene Panel Testing and Family Risk Communication among Racially/Ethnically Diverse Young Breast Cancer Survivors
多基因面板测试和不同种族/民族的年轻乳腺癌幸存者之间的家庭风险沟通的决策支持
- 批准号:
10657728 - 财政年份:2021
- 资助金额:
$ 15.45万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.45万 - 项目类别:
Research Grant